Key statistics
On Friday, Allogene Therapeutics Inc (ALLO:NSQ) closed at 1.80, 108.79% above the 52 week low of 0.8621 set on May 14, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.63 |
|---|---|
| High | 1.83 |
| Low | 1.63 |
| Bid | 1.75 |
| Offer | 1.80 |
| Previous close | 1.62 |
| Average volume | 5.37m |
|---|---|
| Shares outstanding | 224.73m |
| Free float | 168.64m |
| P/E (TTM) | -- |
| Market cap | 404.51m USD |
| EPS (TTM) | -0.981 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
- Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
- Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
- Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
- Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
- Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
- Allogene Therapeutics Announces Participation in Upcoming Investor Conference
- Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
- Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update
More ▼
